Results 161 to 170 of about 49,774 (199)
Some of the next articles are maybe not open access.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
Cefepime is a potent, broad‐spectrum, fourth‐generation cephalosporin with enhanced activity against most gram‐positive aerobic bacterial pathogens and many gram‐negative aerobic bacteria that are resistant to other cephalosporins. The drug's zwitterionic structure contributes to more rapid penetration of gram‐negative bacterial cell membranes, and its
T C, Hardin, T S, Jennings
openaire +2 more sources
Cefepime is a potent, broad‐spectrum, fourth‐generation cephalosporin with enhanced activity against most gram‐positive aerobic bacterial pathogens and many gram‐negative aerobic bacteria that are resistant to other cephalosporins. The drug's zwitterionic structure contributes to more rapid penetration of gram‐negative bacterial cell membranes, and its
T C, Hardin, T S, Jennings
openaire +2 more sources
Hospital Pharmacy
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing
Andrew R. Staten, Danial E. Baker
openaire +2 more sources
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing
Andrew R. Staten, Danial E. Baker
openaire +2 more sources